Fake drugs across the price spectrum: WHO study


Mumbai, Dec. 22 It is not just highly priced medicines that are prone to counterfeiting. Medicines priced less than Rs 20 are also common targets for counterfeiting, says a recent World Health Organisation (WHO)-funded study that surveyed the extent of counterfeit medicines in the country.

Counterfeits are found in medicines priced below Rs 20, like anti-allergy medicine cetirizine, says Dr D.B.A. Narayana of Delhi Pharmaceutical Trust (DPT), a body mandated by the Mashelkar Committee on spurious drugs (2003) to undertake the study.

P.T. Jyothi Datta
22 December 2007

Read the full story at thehindubusinessline.com.